跳转至内容
Merck
所有图片(1)

Key Documents

更多文件

F8182

Sigma-Aldrich

法罗培南钠 水合物

≥98% (HPLC)

别名:

(5R,6S,8R,2′R)-2-(2′-四氢呋喃基)-6-羟乙基青霉烯-3-羧酸钠盐, ALP 201, SUN 5555, SY 5555, Wy 49605, 呋罗培南, 法罗培南, 法罗培南钠片

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C12H14NNaO5S · xH2O
CAS号:
122547-49-3
分子量:
307.30 (anhydrous basis)
MDL號碼:
MFCD17215925
分類程式碼代碼:
12352200
PubChem物質ID:
329799769
NACRES:
NA.77

品質等級

100

化驗

≥98% (HPLC)

形狀

powder

光學活性

[α]/D +120 to +130°, c = 1.0 in water

儲存條件

desiccated

顏色

white to light brown

溶解度

H2O: ≥20 mg/mL

起源

Daiichi-Sankyo

儲存溫度

−20°C

SMILES 字串

O.[Na+].C[C@@H](O)C1C2SC(C3CCCO3)=C(N2C1=O)C([O-])=O

InChI

1S/C12H15NO5S.Na.H2O/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6;;/h5-7,11,14H,2-4H2,1H3,(H,16,17);;1H2/q;+1;/p-1/t5-,6-,7+,11-;;/m1../s1

InChI 密鑰

FHSVCMPZCIOKGW-VIDQLUEFSA-M

一般說明

法罗培南钠水合物属于口服处方的青霉类抗生素。具有头孢菌素抗性的肠杆菌科细菌感染易受法罗培南的影响。法罗培南可能是治疗由广谱β-内酰胺酶（ESBL）产生细菌引起的尿路感染的一种有效的抗生素。

生化／生理作用

法罗培南钠是一种超广谱、耐受β-内酰胺酶的β-内酰胺抗生素，对革兰氏阳性和革兰氏阴性细菌均具有活性。

特點和優勢

该化合物由Daiichi-Sankyo开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

利福平 ≥95% (HPLC), powder or crystals

Sigma-Aldrich

R3501

利福平

Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.
Hamasuna R, et al.
The Journal of Antimicrobial Chemotherapy, 69(6), 1675-1680 (2014)
H Wakiguchi et al.
The Japanese journal of antibiotics, 48(2), 229-237 (1995-02-01)
Clinical effects of SY5555 dry syrup, a new oral penem antibiotic, were analysed in 20 children with various bacterial infections. Ages of the patients varied from 8 months to 14 years. Doses of SY5555 were varied from 12.8 mg/kg/day to
T Motohiro et al.
The Japanese journal of antibiotics, 48(2), 238-260 (1995-02-01)
Pharmacokinetic, bacteriological and clinical studies on SY5555, a new oral penem, were carried out, and the following results were obtained. 1. MICs were determined for 6 drugs, SY5555, clavulanic acid/amoxicillin (CVA/AMPC), cefaclor (CCL), cefotiam (CTM), cefpodoxime (CPDX), cefdinir (CFDN) against
T Haruta et al.
The Japanese journal of antibiotics, 48(2), 205-209 (1995-02-01)
SY5555 dry syrup (powder to be dissolved before use) was clinically used in pediatric patients. The following results were obtained: 1. The subjects were 6 pediatric patients including 1 case each with pharyngitis, tonsillitis, lacunar tonsillitis and impetigo contagiosa and
M G Cormican et al.
The Journal of antimicrobial chemotherapy, 35(4), 535-539 (1995-04-01)
Furopenem is a novel orally active penem. In this study, furopenem was highly active in vitro against Streptococcus pneumoniae (MIC90 0.03 mg/L), Haemophilus influenzae (MIC90, 2 mg/L), and Moraxella catarrhalls (MIC90, 0.5 mg/L). Its activity was not reduced by a
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门